[1]郝志晔,张 晶,钱 伟,等.参芪排毒汤对宫颈癌组织人乳头瘤病毒E6/E7、P53和PRb基因蛋白表达的影响[J].陕西中医,2021,(2):192-195,199.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.014]
　HAO Zhiye,ZHANG Jing,QIAN Wei,et al.Effect and of Shenqi Paidu decoction on the expression of HPV E6/E7,P53 and PRb in cervical cancer tissues[J].,2021,(2):192-195,199.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.014]
点击复制

参芪排毒汤对宫颈癌组织人乳头瘤病毒E6/E7、P53和PRb基因蛋白表达的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年2期
页码:
192-195,199
栏目:
临床研究
出版日期:
2021-02-05

文章信息/Info

Title:
Effect and of Shenqi Paidu decoction on the expression of HPV E6/E7,P53 and PRb in cervical cancer tissues
作者:
郝志晔1 ; 张 晶2; 钱 伟1 ; 卢雯平1
(1.中国中医科学院广安门医院肿瘤科,北京 100053; 2.深圳市宝安区中医院内分泌科,广东 深圳 518103)
Author(s):
HAO Zhiye; ZHANG Jing; QIAN Wei; LU Wenping
(Department of Oncology,Guang'anmen Hospital,Chinese Academy of Traditional Chinese Medicine,Beijing 100053,China)
关键词:
宫颈癌;  病理组织;  人乳头瘤病毒E6/E7 mRNA;  肿瘤抑制基因;  视网膜母细胞瘤蛋白;  生存函数
Keywords:
Cervical cancer;  Pathological tissue;  Human papillomavirus E6/E7 mRNA;  Tumor suppressor gene;  Retinoblastoma protein;  Survival function
分类号:
R 737.33
DOI:
DOI:10.3969/j.issn.1000-7369.2020.02.014
文献标志码:
A
摘要:
目的:研究参芪排毒汤对宫颈癌组织人乳头瘤病毒(HPV)E6/E7 mRNA、肿瘤抑制基因(P53)、视网膜母细胞瘤蛋白(PRb)表达水平的影响与意义。方法:选取112例宫颈癌患者进入研究,按随机数字表划分成对照组与治疗组,两组均给予新辅助化疗联合腹腔镜宫颈癌根治术治疗,治疗组在新辅助化疗的同时给予参芪排毒汤口服; 术前评估两组临床疗效,统计不良反应发生情况,术中取癌旁健康组织与病灶病理组织样本检测HPV E6和E7 mRNA表达水平并计算E6/E7比值,检测样本中P53、PRb表达水平; 随访至少3年,比较两组患者的3年无病情进展生存时间(PFS)、总生存时间(OS),分析新辅助化疗后病理组织中HPV E6/E7、P53、PRb表达水平对PFS、OS的预测价值。结果:治疗组缓解率为83.93%,对照组为62.50%,治疗组缓解率高于对照组(P<0.05); 治疗组不良反应发生率为12.50%,对照组为17.86%,差异比较无统计学意义(P>0.05); 化疗后两组患者癌旁组织中HPV E6/E7比值比较,差异无统计学意义(P>0.05),病理组中HPV E6/E7表达高于治疗组(均P<0.05),两组癌旁与病理组织中P53、PRb比较,差异有统计学意义(均P>0.05); 化疗后宫颈癌组织中HPV E6/E7、P53、PRb表达水平对于患者无病情进展生存时间PFS、OS均具有较高预测价值(AUC>0.9,P<0.05); 治疗组患者PFS、OS均长于对照组(均P<0.05)。结论:在腹腔镜宫颈癌根治术前新辅助化疗中联合应用参芪排毒汤,能够提高术前疗效,抑制宫颈癌组织中HPV E6/E7表达、提升P53、PRb表达水平,从而起到延长患者无病情进展生存时间与总生存时间,改善预后的作用。
Abstract:
Objective:To study the effect of Shenqi Paidu decoction on the expression levels of human papillomavirus(HPV)E6/E7 mRNA,tumor suppressor gene(P53)and retinoblastoma protein(PRb)in cervical cancer tissues.Methods:A total of 112 patients with cervical cancer were selected for the study and divided into the control group and the treatment group according to the random number table.Both groups were given neoadjuvant chemotherapy combined with laparoscopic radical resection of cervical cancer,and patients in the treatment group were given Shenqi Paidu decoction orally at the same time of neoadjuvant chemotherapy.The clinical efficacy of the two groups was evaluated preoperatively,and the occurrence of adverse reactions was counted.The expression levels of HPV E6 and E7 mRNA were detected by taking healthy tissue samples adjacent to the cancer and pathological tissue samples during the operation,and the E6/E7 ratio was calculated,followed by the detection of the expression levels of P53 and PRb in the samples.Furthermore,patients were followed up for at least 3 years,and the 3-year progression-free survival time(PFS)and total survival time(OS)of the two groups were compared to analyze the predictive value of HPV E6/E7,P53 and PRb expression levels in pathological tissues after neoadjuvant chemotherapy for PFS and OS.Results:The remission rate was 83.93% in the treatment group and 62.50% in the conventional group.The remission rate was higher in the treatment group than that in the conventional group(P<0.05).The incidence of adverse reactions was 12.50% in the treatment group and 17.86% in the conventional group,and there was no statistical difference between the two groups(P>0.05).After chemotherapy,there was no statistically significant difference in the ratio of HPV E6/E7 in the paracancerous tissues of the two groups(P>0.05).The expression of HPV E6/E7 in the pathological group was higher than that in the treatment group(P<0.05).There were statistically significant differences in P53 and PRb in the paracancerous and pathological tissues of the two groups(P>0.05).The expression levels of HPV E6/E7,P53 and PRb in cervical cancer tissues after chemotherapy had high predictive value for PFS and OS in patients(AUC>0.9,all P<0.05).PFS and OS in the treatment group were longer than those in the conventional group(all P<0.05).Conclusion:Combined application of Shenqi Paidu decoction in neoadjuvant chemotherapy before laparoscopic radical resection of cervical cancer can improve the preoperative curative effect,inhibit the expression of HPV E6/E7 in cervical cancer tissue,and enhance the expression level of P53 and PRb,thus prolonging the PFS and OS of patients,and improving the prognosis of these patients.

参考文献/References:

[1] 赵现立,高文丽,高巧莲,等.不同级别宫颈病变中HR-HPV亚型分布研究[J].陕西医学杂志,2019,48(5):647-649,653.
[2] Heng CL,Shi X,Huo D,et al.MiR-449b-5p regulates cell proliferation,migration and radioresistance in cervical cancer by interacting with the transcription suppressor FOXP1[J].Eur J Pharmacol,2019,856(5):172399.
[3] 宋晓婕,李 潇,周艳艳.扶正固本汤对宫颈癌病灶恶性程度及外周血CD68、CD83表达的影响[J].中华中医药学刊,2020,38(4):229-232.
[4] 梅丽君.中药扶正祛瘀汤结合同步放化疗对宫颈癌术后临床疗效的影响[J].内蒙古中医药,2020,39(3):56-57.
[5] 蔡 永.散聚汤加味对宫颈癌术后放化疗患者的癌因性疲乏和免疫功能的改善研究[J].天津中医药,2019,36(11):1069-1072.
[6] 郜智慧,王倩青.疏肝化郁解毒汤对子宫颈癌术后化疗的效果及对血清Th1/Th2水平的影响[J].中华中医药学刊,2020,38(6):240-243.
[7] 孙丽莎,张 娟,王 虹.加减八珍汤联合放化疗治疗中晚期宫颈癌临床观察[J].光明中医,2020,35(7):1041-1042.
[8] 李彩萍.八珍汤加减治疗宫颈癌临床观察[J].光明中医,2019,34(7):1048-1050.
[9] 毛 莉,史晓敏,李彩虹,等.解毒化瘀汤联合新辅助化疗对宫颈癌T细胞亚群和血清肿瘤标志物表达的影响[J].中华中医药学刊,2019,37(6):1529-1532.
[10] Sergio P,Lucia Z,Pecorelli S.Revised FIGO staging for carcinoma of the vulva,cervix,and endometrium [J].International Journal of Gynecology & Obstetrics,2009,105(2):103-104.
[11] 黄诗敏.新辅助化疗加宫颈癌根治术治疗宫颈癌患者的效果观察[J].实用中西医结合临床,2019,19(12):111-112.
[12] 佟春艳,刘丽霞,张彩云,等.术前新辅助化疗治疗局部晚期宫颈癌的效果探讨[J].中国现代药物应用,2020,14(3):82-83.
[13] 邹婷婷,郑春莹,张志邦,等.187例ⅠB2和ⅡA2期宫颈癌新辅助化疗疗效及预后的影响因素[J].中南大学学报:医学版,2020,45(3):297-304.
[14] Deshpande R,Raina P,Shinde K,et al.Flax seed oil reduced tumor growth,modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer[J].Prostaglandins Other Lipid Mediat,2019,143(6):106332.
[15] 强红梅,唐军伟,赵 荣,等.真武汤联合紫杉醇新辅助化疗对宫颈癌病灶恶性程度的影响[J].海南医学院学报,2018,24(8):861-864.
[16] 吴月丽.扶正固本汤联合化疗治疗宫颈癌的临床效果分析[J].中国实用医药,2017,12(24):107-108.
[17] 王小辉,刘紫玲.贞芪扶正颗粒联合顺铂治疗中晚期宫颈癌术后疗效及对患者T淋巴细胞亚群影响[J].陕西中医,2020,41(6):736-739.
[18] 欧丽滢,刘 浩,陈 茵,等.TCT与HPVE6/E7 mRNA定量检测筛查对宫颈癌及癌前病变患者的临床价值[J].广西医科大学学报,2019,36(10):1614-1618.

相似文献/References:

[1]聂金霞,陈 难,邓克红.当归补血汤对宫颈癌荷瘤小鼠抑瘤效果及对免疫调节作用的研究*[J].陕西中医,2019,(3):279.
　NIE Jinxia,CHEN Nan,DENG Kehong..Experimental study on the antitumor effect and immune regulation of Danggui Buxue decoction on cervical cancer bearing mice[J].,2019,(2):279.
[2]徐东英,冯相珍.掌叶半夏有效提取物对宫颈癌大鼠癌组织中Survivin、Caspase-3及Caspase-7的影响[J].陕西中医,2019,(7):832.
　XU Dongying,FENG Xiangzhen..Effect of effective extract of Pinellia ternata on Survivin,Caspase -3 and Caspase -7 in carcinoma of cervical cancer rats[J].,2019,(2):832.
[3]孙立哲,李磊强△,耿翠翠,等.圣愈汤联合放射治疗对人宫颈癌荷瘤小鼠脾脏 DCs 细胞功能的影响*[J].陕西中医,2019,(9):1162.
　SUN Lizhe,LI Leiqiang,GENG Cuicui,et al.Effect of combined radiotherapy and Shengyu decoction treatment on function of splenic DCs in cancerbearing mice[J].,2019,(2):1162.
[4]陈十昔,赵 彦,韩宁宁,等.白头翁汤保留灌肠联合rhGMCSF治疗Ⅱ～Ⅲ期宫颈癌盆腔放疗〖JZ〗所致急性放射性直肠炎疗效及对患者炎症反应的影响*[J].陕西中医,2020,(1):46.
　CHEN Shixi,ZHAO Yan,HAN Ningning,et al.Effect of Baitouweng decoction retention enema combined with rhGMCSF on acute radiation 〖JZ〗proctitis caused by pelvic radiotherapy of stage Ⅱ～Ⅲ cervical cancer and its inflammatory response[J].,2020,(2):46.
[5]王小辉,刘紫玲△.贞芪扶正颗粒联合顺铂治疗中晚期宫颈癌术后疗效及对患者T淋巴细胞亚群影响*[J].陕西中医,2020,(6):736.[doi:DOI:10.3969/j.issn.10007369.2020.06.010]
　WANG Xiaohui,LIU Ziling..Application of Zhenqi Fuzheng granules combined with cisplatin regimen in middle and advanced stage cervical cancer after surgery and the influence on T lymphocyte subsets[J].,2020,(2):736.[doi:DOI:10.3969/j.issn.10007369.2020.06.010]
[6]冯方方,吴 琼,鲁昌辉.清宫排毒汤治疗宫颈癌疗效及对患者肿瘤细胞上皮间质转化的影响[J].陕西中医,2021,(2):187.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.013]
　FENG Fangfang,WU Qiong,LU Changhui.Effect of Qinggong Paidu decoction on the treatment of cervical cancer and its impact on the epithelial-mesenchymal transformation of tumor cells[J].,2021,(2):187.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.013]
[7]杨 繁,曾永蕾.苦参碱对宫颈癌细胞中Bcl-2/Bax表达水平及生物学行为的影响[J].陕西中医,2021,(7):840.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.006]
　YANG Fan,ZENG Yonglei.Effect of matrine on Bcl-2/Bax expression level and biological behavior in cervical cancer cells[J].,2021,(2):840.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.006]
[8]张 鹏,于 勇,万 强,等.补虚养胃汤加减治疗慢性萎缩性胃炎疗效及对患者胃肠功能的影响[J].陕西中医,2022,(1):66.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.016]
[9]吴艳芳,陈 蕾.八珍汤加味联合放疗治疗中晚期宫颈癌疗效及对患者细胞免疫水平和营养状态的影响[J].陕西中医,2022,(8):1052.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.015]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(8197152667)
更新日期/Last Update: 2021-01-28